A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- Doctor Strange Supreme could appear in the movie Doctor Strange 2 Sep 4, 2021
- These products can improve the condition of hair Aug 8, 2020
- Cash not only survived the pandemic – it came out stronger Sep 1, 2021
- Is there a relationship between messenger RNA vaccines and myocarditis? May 28, 2021
- Injured in the knee, Pope Francis consulted the doctor of Atlético Madrid Nov 23, 2022
- Nutritionists have called products ideal for a late supper Aug 15, 2020
- How to safely celebrate Memorial Day May 28, 2021